Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Myst Therapeutics, Inc. is a newly formed biotechnology company focused on the development and commercialization of novel broad spectrum cancer immunotherapy products designed to harness the power of a patient’s own immune system to destroy cancer cells. Myst is pursuing the development of an adoptive cell therapy utilizing enriched T cells from tumors and peripheral blood that target a broad spectrum of cancer mutations.Mys...
Myst Therapeutics, Inc. is a newly formed biotechnology company focused on the development and commercialization of novel broad spectrum cancer immunotherapy products designed to harness the power of a patient’s own immune system to destroy cancer cells. Myst is pursuing the development of an adoptive cell therapy utilizing enriched T cells from tumors and peripheral blood that target a broad spectrum of cancer mutations.Myst believes that combining these will enable the rapid advancement and commercialization these highly promising and innovative broad spectrum cancer therapies addressing a wide range of advanced solid tumors.

List your booth number for exhibitions, ask us